Pharmacoepidemiology Signal Detection & Safety Analysis
Detect and characterize drug safety signals with pharmacoepi rigor
What You Can Do
You leverage pharmacoepidemiology methodology to automatically detect potential safety signals from adverse event data, perform statistical significance testing, and generate evidence-based safety characterizations. Claude analyzes disproportionality metrics, temporal trends, and risk stratification to support regulatory decision-making and clinical trial monitoring with peer-reviewed methodology.
Features
Calculate ROR (Reporting Odds Ratio), PRR (Proportional Reporting Ratio), and IC (Information Component) with confidence intervals to identify adverse events reported more frequently than expected
Apply frequentist and Bayesian methods to determine whether detected signals meet statistical thresholds for further investigation and regulatory escalation
Identify acceleration or deceleration of adverse event reporting over time, with seasonal adjustment and anomaly detection for emerging safety concerns
Segment signals by patient subgroups (age, comorbidities, concomitant medications, dose) to identify at-risk populations and refine safety characterization
Flag incomplete narratives, duplicate reports, data entry errors, and missing covariates that could bias signal detection or confound causality assessment
Organize narratives for manual causality scoring using WHO-UMC or Naranjo criteria, with automated highlighting of key temporal, dechallenge/rechallenge, and alternative cause evidence
Produce formatted safety narratives, risk-benefit summaries, and expedited reporting templates (IND safety reports, MedWatch, EudraVigilance) ready for submission
Synthesize signals across clinical trials, EHR data, insurance claims, and public adverse event databases with source-specific weighting and conflict resolution
Example Output
Signal Detection Summary (Hypothetical):
- Adverse Event: Hepatotoxicity (Standardized MedDRA Query)
- ROR (95% CI): 2.8 (2.1–3.7), statistically significant
- Number of Cases: 42 observed vs. 15 expected
- Temporal Trend: Steady reporting over 18 months; no acceleration
- High-Risk Subgroup: Patients ≥65 years old (ROR 4.2) and those on concomitant statins (ROR 3.5)
- Data Quality: 95% complete narratives; 1 duplicate flagged for deduplication
- Recommendation: Signal confirmed. Escalate to pharmacovigilance committee; consider REMS restriction for high-risk populations
Causality Assessment Narrative (Excerpt):
Case #AR-2026-0847: 68-year-old female, AST/ALT elevated 5× ULN on study day 43, improved post-dechallenge (day 58), re-elevated on rechallenge (day 71). Alternative causes ruled out (no viral serology, no acetaminophen exposure). WHO-UMC assessment: Probable.
Regulatory Report Excerpt (FDA IND Safety Report):
In this interim analysis of Trial XYZ, 42 cases of drug-induced liver injury (DILI) were identified across 5,000 patient-exposures (incidence 0.84%). Disproportionality analysis shows statistically significant signal (ROR 2.8, 95% CI 2.1–3.7). Risk is substantially elevated in patients ≥65 years co-prescribed statins. We recommend amending the protocol to exclude or intensify monitoring in this subgroup.
What's Included
- Signal Detection Framework: Step-by-step methodology for applying pharmacoepidemiology algorithms (ROR, PRR, IC, Bayesian disproportionality) to your adverse event dataset
- Statistical Analysis Templates: Pre-structured prompts for hypothesis formulation, data stratification, sensitivity analysis, and confidence interval interpretation
- Risk Characterization Workbook: Guided analysis of severity, seriousness, mechanism plausibility, dose-response, and temporal relationships for each detected signal
- Causality Assessment Checklist: Interactive tool for organizing case narratives, evaluating WHO-UMC and Naranjo criteria, and documenting causality reasoning
- Regulatory Reporting Templates: Pre-formatted sections for FDA MedWatch, IND safety reports, REMS justification, and EudraVigilance submissions
- Data Validation & QC Forms: Automated checks for duplicate records, missing key fields, outlier narratives, and data integrity issues before analysis
Who It's For
- Pharmacovigilance Specialists
- Clinical Safety Officers and Medical Safety Reviewers
- Regulatory Affairs Professionals preparing safety submissions
- Drug Safety Data Analysts and Epidemiologists
- Clinical Trial Safety Monitors and Data Safety Boards
Best For
- Post-market surveillance signal detection and evaluation
- Periodic safety update reports (PSUR) and risk management planning
- Clinical trial interim safety analyses and safety monitoring
- Risk-benefit characterization for regulatory decision-making
- Expedited adverse event reporting and causality assessment
You might also like
You can quickly organize infectious disease outbreak data into structured investigative frameworks, synthesize complex epidemiological findings into coherent narratives, and produce comprehensive situational reports that prioritize key risks and actionable response strategies. This skill transforms scattered clinical, laboratory, and epidemiological data into clear, decision-ready intelligence for public health response teams.
You can systematically map ethical tensions inherent in public health policy decisions—such as individual autonomy versus collective benefit, liberty versus security, and efficiency versus equity. This skill identifies which populations bear disproportionate burdens, surfaces hidden value assumptions, and documents ethical reasoning transparent enough to withstand legal scrutiny and build stakeholder trust. You'll produce policy ethics memos suitable for agency leadership, legislative testimony, or public comment.
Generate regulatory-compliant policy documents, map complex interagency compliance obligations, and prepare comprehensive federal compliance documentation for audits and funding applications. You'll receive standards-aligned policy language, requirement cross-references, and compliance checklists ready for internal review and submission.
You can create personalized, actionable chronic disease prevention interventions grounded in behavior change science. Claude analyzes patient risk factors, selects appropriate evidence-based frameworks (like TTM or Social Cognitive Theory), and generates detailed prevention plans with specific behavioral targets, motivational strategies, and outcome metrics. You get structured assessment protocols and intervention templates ready to implement with your patients.
Design comprehensive chronic disease prevention interventions that integrate behavior change theory with population-specific tailoring. You'll generate evidence-based strategies for diabetes, heart disease, obesity, and other chronic conditions, complete with implementation blueprints and measurable health outcomes. Each intervention is customized for your target population's demographics, social determinants, and readiness to change.
This skill helps you architect comprehensive workplace wellness initiatives grounded in evidence-based practices and organizational psychology. You'll create tailored programs that align with your company culture, address employee health needs, and deliver measurable outcomes like improved engagement, reduced absenteeism, and enhanced wellbeing metrics. The output includes strategic frameworks, implementation roadmaps, success metrics, and ROI projections.
This skill conducts systematic capability assessments of emergency preparedness programs and identifies critical response gaps. You'll receive a prioritized analysis of capability shortfalls, risk-based recommendations for improvement, and an actionable implementation roadmap. Use it to strengthen public health emergency response readiness and allocate resources to the highest-impact improvements.
This skill generates detailed, customized emergency preparedness plans tailored to your specific location, threats, and organizational needs. It creates actionable response protocols, supply checklists, communication procedures, and evacuation strategies. You get a complete, ready-to-implement emergency framework for households, businesses, schools, or community organizations.